Display Page As Plain Text NASA Bioastronautics Roadmap SLSD JSC
Home | Missions | CC Areas | Disciplines | Risks | R & T Questions | Tasks | Deliverables | Processes | Search | Links | Help
Skip Risk List

Risks

   
 
  Current Selection Filters
 
 
 
 
All
 
 
Skip Risk/EQ/Task List
45 Risks found.
1 Accelerated Bone Loss and Fracture Risk
2 Impaired Fracture Healing
3 Injury to Joints and Intervertebral Structures
4 Renal Stone Formation
5 Occurrence of Serious Cardiac Dysrhythmias
6 Diminished Cardiac and Vascular Function
7 Define Acceptable Limits for Contaminants in Air and Water
8 Immune Dysfunction, Allergies and Autoimmunity
9 Interaction of Space flight Factors, Infections and Malignancy
10 Alterations in Microbes and Host Interactions
12345Next
   
Risk 4: Renal Stone Formation  

 
 
Crosscutting Area : Human Health and Countermeasures
 
jump to contentDiscipline : Bone Loss
 
Description : The potential for renal stone formation may be increased due to elevated urine calcium concentration associated with bone resorption during exposure to hypogravity and to decreased urine volume during periods of dehydration.
 
Context / Risk Factors : This risk may be influenced by environmental factors affecting mineral/fluid status, individual propensity for urine calcium oxalate solubility patterns and stone formation.
 
Justification / Rationale : Space flight is associated with changes in urine chemistry (decreased urinary pH and citrate and increased urinary calcium and phosphate) and composition (increased calcium oxalate and brushite saturation, and increased concentration of undissociated uric acid) which likely contribute to the increased renal stone risk observed during and after space flight. Mitigation strategies (potassium citrate) are currently under investigation.
 
Reference Missions :
 
Skip Mission Links
ISS Lunar Mars
 
 
  Risk Rating
Priority 3
 
  Current Countermeasures
  • Good state of hydration
  • Nutritional counseling
 
  Projected Countermeasures or Mitigations and Other Deliverables with their CRL/TRL scores
  • Nutrition [CRL 4]
  • Pharmacological agents (e.g., Potassium or Magnesium Citrate, bisphosphonates) [CRL 4-8]
  • Urine solubility testing in flight
 
  Research & Technology Questions Skip EQ List
No.
Sorted in Ascending Order
Question Priority
4a What diagnostic measures permit detection of renal calcification during extended-duration space flight? 4
4b What nutritional and/or pharmacological countermeasures adequately minimize risk of stone formation in-flight and upon return to 1-G? 3
4c What is the time course of increased risk for renal stone formation abating upon return to 1-G? 3
 
  Related Risks
Bone Loss
Accelerated Bone Loss and Fracture Risk
Impaired Fracture Healing
Injury to Joints and Intervertebral Structures
Cardiovascular Alterations
Occurrence of Serious Cardiac Dysrhythmias
Nutrition
Inadequate Nutrition
Clinical Capabilities
Monitoring and Prevention
Major Illness and Trauma
Pharmacology of Space Medicine Delivery
 
  Important References
Pak CY, Hill K, Cintron NM, Huntoon C. Assessing applicants to the NASA flight program for their renal stone-forming potential. Aviat Space Environ Med. 1989 Feb;60(2):157-61.
Whitson PA, Pietrzyk RA, Morukov BV, Sams CF. The risk of renal stone formation during and after long duration space flight. Nephron. 2001 Nov;89(3):264-70.
Whitson PA, Pietrzyk RA, Pak CY, Cintron NM. Alterations in renal stone risk factors after space flight. J Urol. 1993 Sep;150(3):803-7.
Whitson PA, Pietrzyk RA, Pak CY. Renal stone risk assessment during Space Shuttle flights. J Urol. 1997 Dec;158(6):2305-10.
Whitson PA, Pietrzyk RA, Sams CF. Space flight and the risk of renal stones. J Gravit Physiol. 1999 Jul;6(1):P87-8.
Whitson PA, Pietrzyk RA, Sams CF. Urine volume and its effects on renal stone risk in astronauts. Aviat Space Environ Med. 2001 Apr;72(4):368-72.
Zerwekh JE. Nutrition and renal stone disease in space. Nutrition. 2002 Oct;18 (10):857-63. Review.
 
NASA
Page Last Updated:  February 12, 2008
Page Editor:  Stuart S. Engelhardt Content Manager:  John B. Charles NASA Official:  John B. Charles Budgets, Strategic Plans, and Accountability Reports Equal Employment Opportunity Data Posted Pursuant to the No Fear Act Information-Dissemination Policies and Inventories Freedom of Information Act President's Management Agenda Privacy Policy & Important Notices Inspector General Hotline Contact SLSD Space Life Sciences Directorate Johnson Space Center USA.gov ExpectMore.gov